BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...
5 天
Pharmaceutical Technology on MSNMenarini to enhance BPDCN detection with VisualDx’s linkThe Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...
An international team led by Professor Barbara Schraml from LMU's Biomedical Center has now carried out an extensive study of a new type of dendritic cell and uncovered its important role in the ...
developed an innovative explainable artificial intelligence (AI) model for analyzing dendritic structures. The team included Misato Tone, also from TUS, and Ippei Obayashi from Okayama University.
LMU researchers have shown that a particular type of immune cell acts more flexibly than ... As the researchers demonstrate, dendritic cells that are marked by expression of the transcription ...
Studying the cell is a difficult and time-consuming process, but scientists have pinpointed generative AI as a potential way to make it easier. The idea is to develop an AI virtual cell that would ...
Angeline shares how Molecular Devices is transforming high-content imaging and cell culture with their AI-enabled systems, including the CellXpress.ai™ Automated Cell Culture System, which uses ...
Identifying and delineating cell structures in microscopy images is ... has now developed a method for retraining the existing AI-based software Segment Anything on over 17,000 microscopy images ...
Gene structure information identified by combining Compugen's AI/ML predictive computational ... tools uncovered high consistency in single-cell expression levels across Ultima's UG 100 sequencing ...
artificial intelligence (AI) has been quietly improving the sector for years, from candidate prioritization in drug discovery to adverse event triage in clinical trials. Still, there are plenty of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果